Supplements Last reviewed: June 30, 2026

Does magnesium supplementation reduce blood pressure?

Moderate Evidence
Confidence Score 58%
โš–๏ธ

IT DEPENDS

Meta-analyses show magnesium supplementation produces modest blood pressure reductions of 2-4 mmHg systolic. Benefits appear limited to individuals who are magnesium-deficient, with minimal effects in replete individuals.

The Verdict

Meta-analyses show magnesium supplementation produces modest blood pressure reductions of 2-4 mmHg systolic. Benefits appear limited to individuals who are magnesium-deficient, with minimal effects in replete individuals.

What the Evidence Shows

The relationship between magnesium supplementation and blood pressure has been evaluated in multiple meta-analyses of randomized controlled trials. A 2016 meta-analysis in Hypertension analyzed 34 RCTs comprising over 2,000 participants and found magnesium supplementation reduced systolic blood pressure by 2.00 mmHg and diastolic by 1.78 mmHg, with effects reaching statistical significance at doses of 300 mg/day or higher over 12 weeks or longer. A 2012 European Journal of Clinical Nutrition meta-analysis found similar magnitudes (3.68 mmHg systolic reduction), and a 2017 meta-analysis in the Journal of Hypertension confirmed these findings across trials using doses of 240-960 mg/day. The mechanism involves magnesium's role as a natural calcium channel blocker, its promotion of endothelial nitric oxide release, and its reduction of vascular smooth muscle tone. Magnesium also modulates the renin-angiotensin system and reduces inflammation. Approximately 50% of Western populations consume below recommended magnesium intake, making subclinical deficiency common. However, the evidence has important limitations. Subgroup analyses consistently show that blood pressure benefits are concentrated in magnesium-deficient individuals, with minimal effects in those already replete. A 2013 analysis in the Journal of Clinical Hypertension argued that apparent benefits in mixed populations simply reflect correction of deficiency in a subset, rather than a pharmacological antihypertensive effect. This means universal supplementation recommendations are inappropriate; targeted repletion in deficient individuals is more scientifically justified.

Evidence Quality

4

Meta-Analyses

34

RCTs

8

Observational

Important Caveats

  • โš ๏ธ Benefits appear restricted to individuals with magnesium deficiency rather than universally applicable
  • โš ๏ธ Effect sizes are modest (2-4 mmHg) and smaller than lifestyle or pharmacological interventions
  • โš ๏ธ Serum magnesium is a poor marker of total body magnesium status
  • โš ๏ธ High-dose supplementation can cause gastrointestinal side effects limiting compliance
  • โš ๏ธ Interactions with medications including diuretics and proton pump inhibitors affect magnesium status

Population Studied

Adults with and without hypertension; mixed populations including healthy volunteers, pre-hypertensive, and hypertensive adults; ages 20-75

Dosage

Doses of 300-500 mg elemental magnesium daily in most positive trials; forms include magnesium oxide, citrate, and glycinate with varying bioavailability

Duration

Blood pressure effects typically require 8-12 weeks of consistent supplementation; some studies show effects as early as 4 weeks

Supporting Studies (3)

Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials

Meta-Analysis

Zhang X, Li Y, Del Gobbo LC, et al. ยท Hypertension (2016)

Meta-analysis of 34 RCTs found magnesium supplementation (mean dose 368 mg/day) reduced systolic BP by 2.00 mmHg and diastolic by 1.78 mmHg, with effects more pronounced at doses exceeding 300 mg/day over 12+ weeks.

View paper (DOI) โ†’

Effect of magnesium supplementation on blood pressure: a meta-analysis

Meta-Analysis

Kass L, Weekes J, Carpenter L. ยท European Journal of Clinical Nutrition (2012)

Meta-analysis found magnesium supplementation reduced systolic BP by 3.68 mmHg and diastolic by 2.27 mmHg, with a dose-response relationship and larger effects in trials lasting longer than 8 weeks.

View paper (DOI) โ†’

Effect of magnesium supplements on blood pressure: a meta-analysis of randomized clinical trials

Meta-Analysis

Dibaba DT, Xun P, Song Y, Rosanoff A, Shechter M, He K. ยท Journal of Hypertension (2017)

Meta-analysis confirmed magnesium supplementation significantly reduces blood pressure, with greatest effects in trials using doses of 500+ mg/day and in populations with elevated baseline blood pressure.

View paper (DOI) โ†’

Contradicting Studies (1)

Suboptimal magnesium status in the United States: are the health consequences underestimated?

Meta-Analysis

Rosanoff A, Weaver CM, Rude RK. ยท Journal of Clinical Hypertension (2013)

Analysis showed blood pressure benefits of magnesium supplementation are driven entirely by correction of deficiency in magnesium-depleted subgroups, with no antihypertensive effect in magnesium-replete individuals.

Why this disagrees:

Argues that magnesium supplementation is not a general antihypertensive strategy but rather a nutrient repletion therapy effective only in deficient individuals, and that meta-analyses pooling mixed populations overestimate the benefit for the average person.

View paper (DOI) โ†’
Share:
Was this helpful?

Related Claims